Search

Your search keyword '"Erro, Maria‐Elena"' showing total 12 results
Start Over Author "Erro, Maria‐Elena"
12 results on '"Erro, Maria‐Elena"'

1. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis

Author

Aguilera-Albesa, Sergio, Amado-Puentes, Alfonso, Arjona-Padillo, Antonio, Arrabal, Luisa, Arratibel, Izascun, Aznar-Laín, Gemma, Bellas-Lamas, Paula, Bermejo, Teresa, Boyero-Durán, Sabas, Camacho, Ana, Campo, Andrea, Campos, Dulce, Cantarín-Extremera, Verónica, Carnero, Cristóbal, Conejo-Moreno, David, Dapena, Marta, Dacruz-Álvarez, David, Delgadillo-Chilavert, Verónica, Deyà, Angela, Estela-Herrero, Jordi, Felipe, Anna, Fernández-Cooke, Elisa, Fernández-Ramos, Joaquín, Fortuny, Claudia, García-Monco, Juan C, Gili, Teresa, González-Álvarez, Verónica, Guerri, Robert, Guillén, Sara, Hedrera-Fernández, Antonio, López, María, López-Laso, Eduardo, Lorenzo-Ruiz, María, Madruga, Marcos, Málaga-Diéguez, Ignacio, Martí-Carrera, Itxaso, Martínez-Lacasa, Xavier, Martín-Viota, Lucía, Martín Gil, Leticia, Martínez-González, María-Jesús, Moreira, Antia, Miranda-Herrero, María C, Monge, Lorena, Muñoz-Cabello, Beatriz, Navarro-Morón, Juan, Neth, Olaf, Noguera-Julian, Antoni, Nuñez-Enamorado, Noemí, Pomar, Virginia, Portillo-Cuenca, Juan C, Poyato, María, Prieto, Luis, Querol, Luis, Rodríguez-Rodríguez, Eloy, Sarria-Estrada, Silvana, Sierra, Concepción, Soler-Palacín, Pere, Soto-Insuga, Víctor, Toledo-Bravo, Laura, Tomás, Miguel, Torres-Torres, Carmen, Turón, Eulàlia, Zabalza, Ana, Armangue, Thaís, Spatola, Marianna, Vlagea, Alexandru, Mattozzi, Simone, Cárceles-Cordon, Marc, Martinez-Heras, Eloy, Llufriu, Sara, Muchart, Jordi, Erro, María Elena, Abraira, Laura, Moris, German, Monros-Giménez, Luis, Corral-Corral, Íñigo, Montejo, Carmen, Toledo, Manuel, Bataller, Luis, Secondi, Gabriela, Ariño, Helena, Martínez-Hernández, Eugenia, Juan, Manel, Marcos, Maria Angeles, Alsina, Laia, Saiz, Albert, Rosenfeld, Myrna R, Graus, Francesc, and Dalmau, Josep

Published
2018
Full Text
View/download PDF

4. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease

Author

Gaig, Carles, Compta, Yaroslau, Heidbreder, Anna, Marti, Maria J, Titulaer, Maarten J, Crijnen, Yvette, Hogl, Birgit, Lewerenz, Jan, Erro, Maria Elena, Garcia-Monco, Juan Carlos, Nigro, Pasquale, Tambasco, Nicola, Patalong-Ogiewa, Maja, Erdler, Marcus, Macher, Stefan, Berger-Sieczkowski, Evelyn, Hoftberger, Romana, Geis, Christian, Hutterer, Markus, Milan-Tomas, Angela, Martin-Bastida, Antonio, Manzanares, Lydia Lopez, Quintas, Sonia, Hoglinger, Gunter U, Mohn, Nora, Schoeberl, Florian, Thaler, Franziska S, Asioli, Gian Maria, Provini, Federica, Plazzi, Giuseppe, Berganzo, Koldo, Blaabjerg, Morten, Bruggemann, Norbert, Farias, Tarsis, Ng, Chen Fei, Giordana, Caroline, Herrero-San Martin, Alejandro, Huebra, Lucio, Kotschet, Katya, Liendl, Herburg, Montojo, Teresa, Morata, Carlos, Perez, Jesus Perez, Puertas, Inmaculada, Seifert-Held, Thomas, Seitz, Caspar, Simabukuro, Mateus Mistieri, Tellez, Nieves, Villacieros-Alvarez, Javier, Willekens, Barbara, Sabater, Lidia, Iranzo, Alex, Cano, Joan Santamaria, Dalmau, Josep, and Graus, Francesc

Subjects
MYORHYTHMIA, SPECTRUM, IGLON5, DYSTONIA, ANTIBODIES, PROGRESSIVE SUPRANUCLEAR PALSY, CHOREA, GAZE PALSY, SLEEP, PATIENT
Abstract

Anti-IgLON5 disease is a recently described neurological disease that shares features of autoimmunity and neurodegeneration. Abnormal movements appear to be frequent and important but have not been characterized and are under-reported. Here we describe the frequency and types of movement disorders in a series of consecutive patients with this disease.

Published
2021

6. Anti-IGLON5 disease

Author

Erro, Maria Elena, primary, Sabater, Lidia, additional, Martínez, Laura, additional, Herrera, María, additional, Ostolaza, Aiora, additional, García de Gurtubay, Iñaki, additional, Tuñón, Teresa, additional, Graus, Francesc, additional, and Gelpi, Ellen, additional

Published
2019
Full Text
View/download PDF

7. Amylin as a potential link between type 2 diabetes and alzheimer disease

Author

Martinez‐Valbuena, Ivan, primary, Valenti‐Azcarate, Rafael, additional, Amat‐Villegas, Irene, additional, Riverol, Mario, additional, Marcilla, Irene, additional, Andrea, Carlos E., additional, Sánchez‐Arias, Juan Antonio, additional, Mar Carmona‐Abellan, Maria, additional, Marti, Gloria, additional, Erro, Maria‐Elena, additional, Martínez‐Vila, Eduardo, additional, Tuñon, Maria‐Teresa, additional, and Luquin, Maria‐Rosario, additional

Published
2019
Full Text
View/download PDF

8. Parkinson's Disease Case Ascertainment in the EPIC Cohort: The NeuroEPIC4PD Study

Author

Gallo, Valentina, Brayne, Carol, Forsgren, Lars, Barker, Roger A, Petersson, Jesper, Hansson, Oskar, Lindqvist, Daniel, Ruffmann, Claudio, Ishihara, Lianna, Luben, Robert, Arriola, Larraitz, Bergareche, Alberto, Gavrila, Diana, Erro, Maria Elena, Vanacore, Nicola, Sacerdote, Carlotta, Bueno-de-Mesquita, Bas, Vermeulen, Roel, Seelen, Meinie, Sieri, Sabina, Masala, Giovanna, Ramat, Silvia, Kyrozis, Andreas, Thricopolou, Antonia, Panico, Salvatore, Mattiello, Amalia, Kaaks, Rudolf, Teucher, Birgit, Katzke, Verena, Kloss, Manja, Curry, Lisa, Calboli, Federico, Riboli, Elio, Vineis, Paolo, Middleton, Lefkos, dIRAS RA-I&I RA, Risk Assessment, Infection & Immunity, LS IRAS EEPI GRA (Gezh.risico-analyse), Gallo, Valentina, Brayne, Carol, Forsgren, Lar, Barker, Roger A, Petersson, Jesper, Hansson, Oskar, Lindqvist, Daniel, Ruffmann, Claudio, Ishihara, Lianna, Luben, Robert, Arriola, Larraitz, Bergareche, Alberto, Gavrila, Diana, Erro, Maria Elena, Vanacore, Nicola, Sacerdote, Carlotta, Bueno de Mesquita, Ba, Vermeulen, Roel, Seelen, Meinie, Sieri, Sabina, Masala, Giovanna, Ramat, Silvia, Kyrozis, Andrea, Thricopolou, Antonia, Panico, Salvatore, Mattiello, Amalia, Kaaks, Rudolf, Teucher, Birgit, Katzke, Verena, Kloss, Manja, Curry, Lisa, Calboli, Federico, Riboli, Elio, Vineis, Paolo, Middleton, Lefkos, dIRAS RA-I&I RA, Risk Assessment, Infection & Immunity, and LS IRAS EEPI GRA (Gezh.risico-analyse)

Subjects
Gerontology, Adult, Male, medicine.medical_specialty, Neurology, Parkinson's disease, Disease, Hypokinesia, Record linkage, Age Distribution, Risk Factors, Epidemiology, Validation, medicine, Humans, Prospective Studies, Prospective cohort study, Exercise, Aged, Aged, 80 and over, business.industry, Incidence, Case ascertainment, Parkinson Disease, Middle Aged, medicine.disease, EPIC study, Prospective Studie, Cohort, Parkinson’s disease, Female, Neurology (clinical), business, Cohort study, Human
Abstract

Background/Aims: Large epidemiological prospective studies represent an important opportunity for investigating risk factors for rare diseases such as Parkinson's disease (PD). Here we describe the procedures we used for ascertaining PD cases in the EPIC (European Prospective Investigation into Cancer and Nutrition) study. Methods: The following three-phase procedure was used: (1) elaboration of a NeuroEPIC4PD template for clinical data collection, (2) identification of all potential PD cases via record linkage and (3) validation of the diagnosis through clinical record revision, in a population of 220,494 subjects recruited in 7 European countries. All cases were labelled with the NeuroEPIC4PD diagnoses of ‘definite', ‘very likely', ‘probable', or ‘possible' PD. Results: A total of 881 PD cases were identified, with over 2,741,780 person-years of follow-up (199 definite, 275 very likely, 146 probable, and 261 possible). Of these, 734 were incident cases. The mean age at diagnosis was 67.9 years (SD 9.2) and 458 patients (52.0%) were men. Bradykinesia was the most frequent presenting motor sign (76.5%). Tremor-dominant and akinetic rigid forms of PD were the most common types of PD. A total of 289 patients (32.8%) were dead at the time of the last follow-up. Conclusions: This exercise proved that it is feasible to ascertain PD in large population-based cohort studies and offers a potential framework to be replicated in similar studies.

Published
2015

9. Autoimmune post-herpes simplex encephalitis of adults and teenagers

Author

Armangue, Thaís, Moris, Germán, Cantarín-Extremera, Verónica, Conde, Carlos Enrique, Rostasy, Kevin, Erro, Maria Elena, Portilla-Cuenca, Juan Carlos, Turón-Viñas, Eulàlia, Málaga, Ignacio, Muñoz-Cabello, Beatriz, Torres-Torres, Carmen, Llufriu, Sara, González-Gutiérrez-Solana, Luis, González, Guillermo, Casado-Naranjo, Ignacio, Rosenfeld, Myrna, Graus, Francesc, and Dalmau, Josep

Subjects
Adult, Male, Young Adult, Adolescent, Humans, Female, Herpes Simplex, Single-Blind Method, Encephalitis, Herpes Simplex, Immunotherapy, Prospective Studies, Middle Aged, Aged
Abstract

To report 14 patients with immune-mediated relapsing symptoms post-herpes simplex encephalitis (HSE) and to compare the clinical and immunologic features of the teenage and adult group with those of young children.

Published
2015

10. Colaboradores

Author

Agundez, Marta, Ara, José Ramón, Arias, Manuel, Arias-Rivas, Susana, Bárcena, Joseba, Barredo, Jennifer, Berciano, José Ángel, Berganzo, Koldo, Blanco, Elisa, Blázquez, Marta, Boyero, Sabas, Bruna, Jordi, Caballero, Iván, Cabellos, Carmen, Cabrera, Alberto, Castillo, José, Duat, Anna, Erro, María Elena, Fernández, Manuel, Fernández, Tamara, Fernández-Vega, Iván, Galbarriatu, Lara, Garamendi, Íñigo, García-Ribes, Ainhoa, Gómez-Esteban, Juan Carlos, González, Amaya, González-Menacho, Jordi, Gramunt, Nina, Graus, Francesc, Gutiérrez-Gutiérrez, Gerardo, Gutiérrez-Rivas, Eduardo, Illa, Isabel, Infante, Jon, Irizar, Haritz, Jáuregui, Amaya, Kapetanovic, Solange, Laínez, José Miguel, Lambarri, Imanol, Munain, Adolfo López de, Losada, José, Luna, Alain, Luquin, Rosario, Marinas, Ainhoa, Martí, Itxaso, Martínez-Salio, Antonio, Martínez-Yélamos, Sergio, Mateos, Beatriz, Matos, Nuria, Matutes, Alejandra, Mendibe, Mar, Minguez-Castellanos, Adolfo, Molinuevo, José Luis, Olivé, Montserrat, Otaegui, David, Pascual, Julio, Rodeño, Emilia, Rodrigo, Rosa Mónica, Rodríguez, Olivia, Rodríguez-Yáñez, Manuel, Rouco, Idoia, Sáenz, Amets, Saiz, Albert, Santamaría, Joan, Serratosa, José María, Somme, Johanne, Tijero, Beatriz, Ugarriza, Iratxe, Valle, Elena, Valle, María Antonia, Velasco, Fernando, Velasco, Leticia, Zarranz, Daniel, and Zarranz, Juan José

Published
2018
Full Text
View/download PDF

11. Autoimmune post–herpes simplex encephalitis of adults and teenagers

Author

Armangue, Thaís, primary, Moris, Germán, additional, Cantarín-Extremera, Verónica, additional, Conde, Carlos Enrique, additional, Rostasy, Kevin, additional, Erro, Maria Elena, additional, Portilla-Cuenca, Juan Carlos, additional, Turón-Viñas, Eulàlia, additional, Málaga, Ignacio, additional, Muñoz-Cabello, Beatriz, additional, Torres-Torres, Carmen, additional, Llufriu, Sara, additional, González-Gutiérrez-Solana, Luis, additional, González, Guillermo, additional, Casado-Naranjo, Ignacio, additional, Rosenfeld, Myrna, additional, Graus, Francesc, additional, and Dalmau, Josep, additional

Published
2015
Full Text
View/download PDF

12. Anti-IGLON5 disease: A new case without neuropathologic evidence of brainstem tauopathy.

Author

Erro ME, Sabater L, Martínez L, Herrera M, Ostolaza A, García de Gurtubay I, Tuñón T, Graus F, and Gelpi E

Subjects
Aged, Autoantibodies blood, Autoantibodies cerebrospinal fluid, Autopsy, Brain pathology, Brain Stem metabolism, Brain Stem pathology, Fatal Outcome, Humans, Male, Phosphorylation physiology, Autoantibodies metabolism, Brain metabolism, Cell Adhesion Molecules, Neuronal immunology, Tauopathies immunology, Tauopathies metabolism, tau Proteins metabolism
Abstract

Objective: To describe the neuropathologic features and the molecular data of phosphorylated tau (pTau) in a new case of anti-IgLON5 disease., Methods: Review of clinical data, postmortem neuropathologic examination. Biochemical analyses of pTau were performed in brain samples from the present case and from a previously described patient with anti-IgLON5 with the characteristic brainstem tauopathy., Results: The patient was a 71-year-old man with a clinical syndrome consisting of sleep disturbance and bulbar symptoms. IgLON5 antibodies of predominant IgG4 subtype were detected in serum and CSF. He carried the HLA DRB1*10:01-DQB1*05:01 haplotype. Despite treatment with IV immunoglobulins, he unexpectedly died during sleep 2 years after disease onset. Histology showed neurofibrillary pathology and β-amyloid deposits consistent with Alzheimer disease (AD) of intermediate severity. pTau deposits were absent in the brainstem. There were few perivascular CD8 + T-cell infiltrates in the posterior hypothalamus, amygdala, and brainstem with microglial activation. The pTau immunoblot showed a pattern of bands consistent with AD, which was different from that observed in the patient with anti-IgLON5 with brainstem tauopathy who presented a differential band around 56 KDa., Conclusion: The absence of pTau deposits in the brainstem of the present patient suggests that the tauopathy of patients with anti-IgLON5 disease may be a late, secondary event. The anti-IgLON5 brainstem tauopathy has a specific molecular signature different from primary tauopathies. pTau deposits restricted to the hippocampus/limbic regions of patients with anti-IgLON5 may represent an age-related comorbidity., (Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.)

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results